-
iClinic Healthcare looks to raise Rs 25 cr to fund expansion
Online healthcare provider iClinic Healthcare is in talks with investors to raise Rs 25 crore to fund its expansion in India.
- Categories
- Health Care
- Region
- South Asia
-
India’s new government vows clampdown on healthcare graft
India's health minister called for tougher laws on Tuesday after a media report alleged that laboratories had offered kickbacks to doctors who referred patients to their diagnostic centres.
- Categories
- Health Care
- Region
- South Asia
-
A new kind of no-frills bank could kickstart India’s long-awaited mobile money revolution
The Reserve Bank of India (RBI) is one of the few institutions Indians respect (paywall). India’s central bank is known for being clean, sensible, and well-run. It is also extremely cautious
- Categories
- Uncategorized
- Region
- South Asia
-
Financial Inclusion in Paraguay: New Mobile Money Regulation
The opportunity to increase financial access in Paraguay is massive.
- Categories
- Uncategorized
- Region
- Latin America
-
The BRICS new development bank: A historic game-changer?
Following two years of intense negotiations, the BRICS leaders agreed on 15 July 2014 in Fortaleza (Brazil) to launch the New Development Bank (NDB).
- Categories
- Impact Assessment
- Region
- South Asia
-
Does the World Still Need the World Bank?
There will always be a need for a World Bank, which celebrates a birthday of sorts Tuesday. There is no need for a World Bank with more than 10,000 employees.
- Categories
- Uncategorized
-
OPINION: Leveraging economic supply chains for extending health solutions to the Bottom of Pyramid (BoP)
Products and services that are of relevance to public health need a supply chain to reach the bottom of the pyramid (BoP). They need to reach the last mile with the least transaction cost and in a sustainable manner, irrespective of the type of money that is involved (investor capital, grant etc). These services and products also need a channel. Establishing a channel for them, with least cost and long term viability has been the challenge to date in a country such as India. It is in this context that it becomes relevant to look at existing market mechanisms that are already reaching large BoP populations in rural and semi-urban areas, where some level of aggregation has already taken place.
- Categories
- Environment, Health Care
-
Price caps on drugs hurt Indian units of global pharma firms
Widening of price controls adds pressure on the local units of global manufacturers to boost sales volumes
- Categories
- Health Care
- Region
- South Asia
